Salud financiera de hoja de balance de SK ChemicalsLtd

Salud financiera controles de criterios 5/6

SK ChemicalsLtd tiene un patrimonio de accionistas total de ₩2,675.8B y una deuda total de ₩1,093.2B, lo que sitúa su ratio deuda-patrimonio en 40.9%. Sus activos y pasivos totales son ₩4,158.8B y ₩1,483.0B respectivamente. El BAIT de SK ChemicalsLtd es de ₩83.7B, por lo que su ratio de cobertura de intereses es de 7.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₩1,600.4B.

Información clave

40.9%

Ratio deuda-patrimonio

₩1.09t

Deuda

Ratio de cobertura de intereses	7.3x
Efectivo	₩1.60t
Patrimonio	₩2.68t
Total pasivo	₩1.48t
Activos totales	₩4.16t

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Mar 22

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Mar 02

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

Feb 08

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Dec 30

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Dec 09

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Nov 19

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩2,202.5B) de A285130 superan a sus pasivos a corto plazo (₩830.2B).

Pasivo a largo plazo: Los activos a corto plazo de A285130 (₩2,202.5B) superan a sus pasivos a largo plazo (₩652.8B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: A285130 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de A285130 ha pasado de 125.5% a 40.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de A285130 no está bien cubierta por el flujo de caja operativo (13.4%).

Cobertura de intereses: Los pagos de intereses de la deuda de A285130 están bien cubiertos por el BAIT (7.3x cobertura).

Salud financiera de hoja de balance de SK ChemicalsLtd

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

SK chemicals Unveils Blueprint for Circular Recycle™ and Solutions

SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩2,072 (vs ₩9,910 in FY 2022)

There Is A Reason SK Chemicals Co.,Ltd's (KRX:285130) Price Is Undemanding

Upcoming dividend of ₩1,100 per share at 2.2% yield

Third quarter 2023 earnings released: EPS: ₩2,441 (vs ₩1,815 in 3Q 2022)

Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130).

New minor risk - Profit margin trend

Upcoming dividend of ₩400 per share at 1.5% yield

First quarter 2023 earnings released: EPS: ₩816 (vs ₩1,881 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to ₩130,000

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Price target increased to ₩333,333

Price target increased to ₩333,333

Upcoming dividend of ₩1,333 per share

Metrica Partners Calls for a Strategic Review at SK Chemicals

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Metrica Partners Sends Letter to SK Chemicals

We Think SK ChemicalsLtd's (KRX:285130) Robust Earnings Are Conservative

Full year 2020 earnings released: EPS ₩621 (vs ₩1,318 loss in FY 2019)

Should You Think About Buying SK Chemicals Co.,Ltd. (KRX:285130) Now?

Investor sentiment deteriorated over the past week

SK Chemicals Co.,Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day low: ₩347,000

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Daejung Chemicals & Metals Co.,Ltd. (KOSDAQ:A120240) acquired 50% in Sk Chemicals Daejung Co,. Ltd from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 6 billion.

Price target raised to ₩513,333

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

New 90-day high: ₩462,500

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Standigm Inc. and K Chemicals Co., Ltd. Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Upcoming Dividend of ₩450 Per Share

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Analysts increase EPS estimates to ₩17,352

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Analysts update estimates

New 90-day high: ₩449,500

Kyung-joo Park and other investors acquired 16.03% stake in JSI Co. Ltd. from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 0.04 million.

New 90-day high - ₩314,000

Price target raised to ₩183,750

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera